Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2091]
News [6469]
Articles [133]
Editorials [5]
Conferences [171]
elearning [10]
Early stage biomarkers in ovarian cancer
Prof Angelo Paradiso – National Cancer Research Institute, Bari, Italy
Early stage biomarkers in ovarian cancer ( Prof Angelo Paradiso – National Cancer Research Institute, Bari, Italy )
15 Nov 2012
Drug approval process for ovarian cancer
Prof Maria Paolo Costi – University of Modena, Italy
Drug approval process for ovarian cancer ( Prof Maria Paolo Costi – University of Modena, Italy )
15 Nov 2012
Inequalities in cancer incidence, mortality and survival
Dr Michel Coleman - London School of Hygiene and Topical Medicine, London, UK
Inequalities in cancer incidence, mortality and survival ( Dr Michel Coleman - London School of Hygiene and Topical Medicine, London, UK )
14 Nov 2012
Drug susceptibility in cancer cell lines
Dr Lodewyk Wessels – Netherlands Cancer Institute, Amsterdam
Drug susceptibility in cancer cell lines ( Dr Lodewyk Wessels – Netherlands Cancer Institute, Amsterdam )
14 Nov 2012
Effectiveness of PARP inhibitors in ovarian cancer
Prof Jonathan Ledermann - University College London, UK
Effectiveness of PARP inhibitors in ovarian cancer ( Prof Jonathan Ledermann - University College London, UK )
1 Nov 2012
The Cancer Genome Atlas and high grade serous ovarian cancer
Dr Andrew Berchuck – Duke University Medical Center, Durham, USA
The Cancer Genome Atlas and high grade serous ovarian cancer ( Dr Andrew Berchuck – Duke University Medical Center, Durham, USA )
30 Oct 2012
6th International Workshop on Myeloma Pharmacogenomics and Novel Therapeutics
Prof Keith Stewart, Prof Gareth Morgan, Dr Stuart Smith
6th International Workshop on Myeloma Pharmacogenomics and Novel Therapeutics ( Prof Keith Stewart, Prof Gareth Morgan, Dr Stuart Smith )
23 Oct 2012
Progress of personalised oncology treatment
Prof Martine Piccart – President-Elect of ECCO
Progress of personalised oncology treatment ( Prof Martine Piccart – President-Elect of ECCO )
22 Oct 2012
Pathology and development of ovarian cancer
Dr Jamie Prat – Hospital De La Santa Creu I San Pau, Spain
Pathology and development of ovarian cancer ( Dr Jamie Prat – Hospital De La Santa Creu I San Pau, Spain )
9 Oct 2012
Putting the theory of personalised medicine into practice
Prof Fabrice Andre, Dr Ramesh Ramanathan, Prof Peter Harper and Prof Robert...
Putting the theory of personalised medicine into practice ( Prof Fabrice Andre, Dr Ramesh Ramanathan, Prof Peter Harper and Prof Robert Leonard )
8 Oct 2012
Treatment of ALK+ lung cancer with crizotinib, Profile 1007
Dr Alice Shaw – Massachusetts General Hospital, Boston, USA
Treatment of ALK+ lung cancer with crizotinib, Profile 1007 ( Dr Alice Shaw – Massachusetts General Hospital, Boston, USA )
8 Oct 2012
Phase III MISSION trial: Sorafenib does not extend overall survival as third or...
Dr Tony Mok – The Chinese University of Hong Kong
Phase III MISSION trial: Sorafenib does not extend overall survival as third or fourth line therapy in lung cancer ( Dr Tony Mok – The Chinese University of Hong Kong )
8 Oct 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation